Ravi Ramessur

King's College London — United Kingdom

Immunology and Microbiology · Life Sciences

8h-index634citations50works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(16), Asthma and respiratory diseases(10), Dermatology and Skin Diseases(8), Retinoids in leukemia and cellular processes(5), Urticaria and Related Conditions(4)

Publications49 total

Additional file 2 of Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Additional file 1 of Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Additional file 1 of Genetic liability to psoriasis predicts severe disease outcomes
Research Portal (King's College London)·2026Open Access
Additional file 2 of Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Genetic liability to psoriasis predicts severe disease outcomes
Genome Medicine·2025Open Access
Sleep and psoriasis: an emerging modifiable risk factor?
British Journal of Dermatology·2025
The Inflammatory Skin Disease map: an interactive computational resource focused on molecular mechanisms in psoriasis and atopic dermatitis
British Journal of Dermatology·2025Open Access
100 Circulating metabolites associated with psoriasis in ~300,000 individuals from the UK Biobank and HUNT3 Study
Journal of Investigative Dermatology·2025Open Access
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors
Journal of the American Academy of Dermatology·2025Open Access
National clinical reaudit on managing adults with bullous pemphigoid 2024 highlighting shifting clinical practices
Skin Health and Disease·2025Open Access
Circulating metabolites associated with psoriasis in the UK Biobank and the HUNT Study: A cross-sectional study of 270,848 participants
2025Open Access
Genetic proxies of GLP1R expression in whole blood are associated with lower risk of psoriasis and psoriatic arthritis
2025Open Access
Deucravacitinib for the treatment of moderate-to-severe palmoplantar pustulosis: Results from an early-terminated open-label trial
JAAD International·2025Open Access
Facing Our FAERS: Disproportionality Analyses, Signal Detection, and Interpretation
Journal of Investigative Dermatology·2025· 1 citedOpen Access
Multi-omic triangulation identifies molecular candidates of atopic dermatitis severity
2025Open Access
Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction
2025· 2 citedOpen Access
P062 National clinical reaudit on managing adults with bullous pemphigoid 2024: shifting clinical practices
British Journal of Dermatology·2025Open Access
BG02 (P062) National clinical reaudit on managing adults with bullous pemphigoid 2024: shifting clinical practices
British Journal of Dermatology·2025Open Access
page 1 of 3Next →

Frequent Co-authors

Catherine Smith(19), Nick Dand(17), Jake Saklatvala(14), Satveer K. Mahil(9), Juliet N. Barker(9), Lavinia Paternoster(9), Katie Watts(9), Mari Løset(8), David Baudry(8), Sandro Bruno(8), Tanel Traks(8), Marek Ostaszewski(7), Matladi Ndlovu(7), Michael A. Simpson(7), Sara Brown(7), Bjørn Olav Åsvold(7), Laura Huilaja(7), Manpreet K. Sagoo(7), Márcio Luís Acencio(6), Stephan Weidinger(6)